Two Ex-GSK AI Leads Go Stealth with a New Oncology Drug Discovery Startup

Clockwork Bio has been launched as a new AI-native biotech focused on redesigning early-stage oncology drug discovery. The company is developing a platform centered on modeling and controlling cell state transitions, aiming to address limitations in current pipelines that struggle with complex, heterogeneous diseases such as cancer.